Seeking Alpha

Amarin (AMRN +1.2%) says the USPTO has granted a Notice of Allowance for patent protection of...

Amarin (AMRN +1.2%) says the USPTO has granted a Notice of Allowance for patent protection of its Vascepa, a prescription grade omega-3 fatty acid that can help reduce triglyceride levels in adults. The issued patent would have a term that expires no earlier than in 2030.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector